Photobiomodulation Modulates Peripheral and Central Expression of Inflammation-Related Genes Following Carrageenan-Induced Inflammation in Rats
This study demonstrates that localized photobiomodulation (PBM) effectively modulates both peripheral and central inflammation-related gene expression in rats following carrageenan-induced inflammation by reducing pro-inflammatory markers (IL-6, IP, and kinin receptors) while sustaining elevated anti-inflammatory IL-10 levels.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human body is not a collection of isolated parts; it is a single, communicating system where a problem in a foot can send a message to the brain. When tissue is injured, the immune system launches a defense, releasing chemical signals that travel through the blood and along nerves to alert the central nervous system. This conversation between the body's edge and its core is vital for survival, but when it goes on too long or becomes too loud, it can lead to chronic pain and neurological issues. Scientists have long known that inflammation in a limb can trigger changes in the brain, yet the specific molecular messages exchanged during this process remain complex. Understanding how to gently interrupt or calm these signals without using drugs is a major goal for researchers seeking better ways to manage pain and inflammation.
In a recent study, researchers set out to see if a specific type of light therapy could change the way these messages are written. They focused on a technique called photobiomodulation, which uses a low-power laser to shine on injured tissue. The team worked with rats, injecting a substance called carrageenan into the bottom of their paws to create a controlled, temporary inflammation. This substance is known to cause swelling and pain, mimicking the body's natural reaction to injury. The researchers wanted to know if shining a red laser light on the inflamed paw, one hour after the injection, could alter the genetic instructions inside the cells. Specifically, they looked for changes in the instructions for making proteins that either fuel the fire of inflammation or help to put it out. They examined these instructions, known as mRNA, in two places: the actual injured paw and the brain, to see if the light's effect stayed local or traveled to the center of the nervous system.
The experiment was carefully timed. The researchers divided the animals into groups and checked their tissues at one, three, and six hours after the injection. In the groups that received the laser treatment, the light was applied to the paw for just under three minutes. The laser emitted a specific shade of red light, with a wavelength of 660 nanometers, delivering a precise amount of energy to the skin. After the designated time, the researchers removed the brain and the paw tissue to measure the levels of several key genes. They looked for genes related to interleukin-6, a protein that promotes inflammation; interleukin-10, a protein that helps calm it down; and several receptors that act as antennas for pain-signaling chemicals like kinins and prostacyclins.
The results showed that the inflammation caused a clear, time-dependent shift in the genetic activity of both the paw and the brain. Without any treatment, the levels of the inflammatory gene interleukin-6 rose significantly in the paw and the brain, peaking six hours after the injury. Similarly, the genes for the prostacyclin receptor and the kinin B1 and B2 receptors, which are involved in sensing pain and swelling, increased at specific times during the six-hour window. However, in the animals that received the laser treatment, this pattern changed. The light therapy significantly reduced the levels of the inflammatory interleukin-6 and the prostacyclin receptor in both the paw and the brain at the six-hour mark. It also lowered the levels of the kinin receptors at the times they were most active.
Perhaps more importantly, the treatment did not just suppress the bad signals; it helped maintain the good ones. In the untreated animals, the levels of the calming interleukin-10 gene in the brain began to drop after three hours. But in the animals treated with the laser, the levels of this protective gene remained high at the six-hour mark. This suggests that the light therapy did not simply shut down the immune system's response. Instead, it appeared to fine-tune the conversation, turning down the volume on the signals that cause pain and swelling while keeping the signals that promote healing and regulation active.
The study confirms that a localized treatment on a limb can influence the genetic activity deep within the brain. The researchers found that the light therapy created a coordinated change across the body, reducing pro-inflammatory markers and preserving anti-inflammatory ones in both the injured tissue and the central nervous system. This indicates that the benefits of this light therapy are not limited to the spot where the beam hits. The findings suggest that photobiomodulation can modulate the complex chemical dialogue between the body and the brain, offering a non-invasive way to influence how the nervous system responds to injury. While the exact mechanism of how the light signal travels from the paw to the brain remains to be fully mapped, the evidence shows that the treatment successfully altered the molecular response to inflammation in a way that could be beneficial for managing pain.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.